UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psychological and pain effects of the use of the max mode of the Fotona Fidelis Er:YAG laser on patients, in Class I cavity preparations

Medicina oral, patología oral y cirugía bucal, 2012, p.S35-.

Tzannou, E.

2012

Volltextzugriff (PDF)

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Volltextzugriff (PDF)

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Volltextzugriff (PDF)

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical cancer research, 2023-01, Vol.29 (2), p.324-330

2023

Volltextzugriff (PDF)

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221107113

2022

Volltextzugriff (PDF)

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Blood, 2021-05, Vol.137 (19), p.2585-2597

2021

Volltextzugriff (PDF)

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1415-1425

2021

Volltextzugriff (PDF)

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Blood advances, 2019-09, Vol.3 (17), p.2571-2580

2019

Volltextzugriff (PDF)

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Blood, 2022-04, Vol.139 (17), p.2706-2711

2022

Volltextzugriff (PDF)

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

Science translational medicine, 2020-07, Vol.12 (554)

2020

Volltextzugriff (PDF)

Treatment of Severe, Drug-Refractory Viral Infections with Allogeneic, Off-the-Shelf Multi-Virus Specific T Cells in Patients Following HSCT: Results from a Phase 2 Study

Blood, 2020-11, Vol.136 (Supplement 1), p.2-3

2020

Volltextzugriff (PDF)

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

Blood, 2017-12, Vol.130, p.1907-1907

2017

Volltextzugriff (PDF)

PB2140: ALLOGENEIC STEM CELL TRANSPLANTATION IN RARE T‐NHL SUBTYPES: FOCUS ON AITL, MF/SS, HSTCL. A SINGLE BMT‐UNIT EXPERIENCE

HemaSphere, 2022-06, Vol.6 (Suppl), p.2011-2012

2022

Volltextzugriff (PDF)

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Blood, 2021-11, Vol.138 (Supplement 1), p.471-471

2021

Volltextzugriff (PDF)

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Blood, 2018-11, Vol.132 (Supplement 1), p.2693-2693

2018

Volltextzugriff (PDF)

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Blood, 2018-11, Vol.132 (Supplement 1), p.1685-1685

2018

Volltextzugriff (PDF)

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Blood, 2017-12, Vol.130, p.164-164

2017

Volltextzugriff (PDF)

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Blood, 2015-12, Vol.126 (23), p.186-186

2015

Volltextzugriff (PDF)

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Blood, 2015-12, Vol.126 (23), p.622-622

2015

Volltextzugriff (PDF)

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Blood, 2015-12, Vol.126 (23), p.1926-1926

2015

Volltextzugriff (PDF)

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Blood, 2016-12, Vol.128 (22), p.501-501

2016

Volltextzugriff (PDF)

Abstract IA22: Immunotherapy with virus-specific T cells

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.IA22-IA22

2016

Volltextzugriff (PDF)

Skin Cancer in the Elderly

In vivo (Athens), 2005-05, Vol.19 (3), p.643-652

2005

Volltextzugriff (PDF)

P2095 Carbapenem consumption and resistance of P. aeruginosa and K. pneumoniae to carbapenems: results from a 7-year study in a general hospital

International journal of antimicrobial agents, 2007, Vol.29, p.S605-S606

2007

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation And Cellular Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Hematology, Oncology And Palliative Medicine
(9)
Humans
(8)
Adult
(5)
Female
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Male
(4)
Oncology
(4)
T-Lymphocytes - Immunology
(4)
Adolescent
(3)
Aged
(3)
Child
(3)
Hematology
(3)
Medicine, Research & Experimental
(3)
Middle Aged
(3)
Research & Experimental Medicine
(3)
T-Lymphocytes - Transplantation
(3)
Young Adult
(3)
Antigens, Neoplasm - Immunology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychological and pain effects of the use of the max mode of the Fotona Fidelis Er:YAG laser on patients, in Class I cavity preparations

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

Treatment of Severe, Drug-Refractory Viral Infections with Allogeneic, Off-the-Shelf Multi-Virus Specific T Cells in Patients Following HSCT: Results from a Phase 2 Study

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

PB2140: ALLOGENEIC STEM CELL TRANSPLANTATION IN RARE T‐NHL SUBTYPES: FOCUS ON AITL, MF/SS, HSTCL. A SINGLE BMT‐UNIT EXPERIENCE

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Abstract IA22: Immunotherapy with virus-specific T cells

Skin Cancer in the Elderly

P2095 Carbapenem consumption and resistance of P. aeruginosa and K. pneumoniae to carbapenems: results from a 7-year study in a general hospital

Aktive Filter

Suchergebnisse filtern